A global study, in which the LDI participated, has identified a specific gene variant that protects against severe infection by COVID-19.
As the new Director of the Lady Davis Institute, Dr. Stephen Robbins hopes to see the LDI gain even more global prominence.
The JGH is playing a key role in Canada’s largest biobank, which collects and stores samples of COVID-19 to help researchers better understand and fight the virus.
Dr. Stephen Robbins, new Director of the Lady Davis Institute, and Dr. Donna Senger, of the LDI’s Cancer Axis, have received up to $6.7 million in federal support for a drug candidate that could bring relief to hospitalized patients with a severe case of COVID-19.
A major expansion is on the way for the biobank at the JGH that collects and stores biological samples of COVID-19 for research.
A ground-breaking new study has succeeded in compiling an “atlas” of genetic factors that are associated with estimated bone mineral density, one of the most clinically relevant factors in diagnosing osteoporosis.
The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.